Cita APA (7a ed.)
Cai, D., Chen, Q., Mao, L., Xiao, T., Wang, Y., Gu, Q., . . . Sun, L. (2024). Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients. European Journal of Clinical Pharmacology, 80(4), 613-621.
Cita Chicago Style (17a ed.)
Cai, Dabei, Qianwen Chen, Lipeng Mao, Tingting Xiao, Yu Wang, Qingqing Gu, Qingjie Wang, Yuan Ji, y Ling Sun. "Association of SGLT2 Inhibitor Dapagliflozin with Risks of Acute Kidney Injury and All-cause Mortality in Acute Myocardial Infarction Patients." European Journal of Clinical Pharmacology 80, no. 4 (2024): 613-621.
Cita MLA (9a ed.)
Cai, Dabei, et al. "Association of SGLT2 Inhibitor Dapagliflozin with Risks of Acute Kidney Injury and All-cause Mortality in Acute Myocardial Infarction Patients." European Journal of Clinical Pharmacology, vol. 80, no. 4, 2024, pp. 613-621.
Precaución: Estas citas no son 100% exactas.